World's Best Scientists 2026 revealed!
Eric Hachulla

Eric Hachulla

Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
124
Citations
58386
World Ranking
3219
National Ranking
88

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Eric Hachulla is affiliated with the University of Lille in France and specializes in medical research with a focus on rheumatology and related fields. Their work encompasses a broad spectrum of study areas within medicine, particularly emphasizing pathology and forensic medicine, pulmonary and respiratory medicine, rheumatology, epidemiology, and immunology.

Their research topics cover multiple systemic and inflammatory diseases, with notable concentrations on systemic sclerosis and related conditions, interstitial lung diseases and idiopathic pulmonary fibrosis, systemic lupus erythematosus, inflammatory myopathies and dermatomyositis, salivary gland disorders, vasculitis and related conditions, as well as dermatologic treatments and research.

Eric Hachulla has published extensively in various scientific venues. Among the most frequent publication venues are:

  • Annals of the Rheumatic Diseases
  • La Revue de Médecine Interne
  • Lara D. Veeken
  • Revue du Rhumatisme
  • RMD Open

Some of their recent papers include:

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry, 2021, Annals of the Rheumatic Diseases
  • Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis, 2020, Autoimmunity Reviews
  • Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database, 2020, Annals of the Rheumatic Diseases
  • COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study, 2021, The Lancet Rheumatology
  • Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, 2020, Annals of Internal Medicine

Frequent collaborators in their research include:

  • David Launay
  • M. Lambert
  • Luc Mouthon
  • Vincent Sobanski
  • Véronique Le Guern

The focus on systemic and inflammatory diseases such as systemic sclerosis, interstitial lung diseases, and vasculitis reflects a broad and multidisciplinary approach to medical research involving immunological, pathological, and clinical domains.

Best Publications

  • Pulmonary arterial hypertension in France: results from a national registry.

    Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi

  • Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

    Ricard Cervera;Jean Charles Piette;Josep Font;Munther A. Khamashta

  • Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

    Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Use of canakinumab in the cryopyrin-associated periodic syndrome.

    Helen J Lachmann;Isabelle Kone-Paut;Jasmin B Kuemmerle-Deschner;Kieron S Leslie

  • Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

    Eric Hachulla;Virginie Gressin;Loïc Guillevin;Patrick Carpentier

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

  • Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

    R. Cervera;M. A. Khamashta;Y. Shoenfeld;M. T. Camps

  • Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

    Sophie Delalande;Jérôme de Seze;Anne-Laure Fauchais;Eric Hachulla

  • A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis

    Loïc Guillevin;Jean-François Cordier;Franïois Lhote;Pascal Cohen

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Anja Strangfeld;Martin Schäfer;Milena A Gianfrancesco;Saskia Lawson-Tovey

  • Interstitial lung disease in polymyositis and dermatomyositis.

    I. Marie;E. Hachulla;P. Chérin;S. Dominique

  • Infections in 252 patients with common variable immunodeficiency.

    Eric Oksenhendler;Laurence Gérard;Claire Fieschi;Marion Malphettes

  • EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

    Raphaele Seror;Philippe Ravaud;Xavier Mariette;Xavier Mariette;Hendrika Bootsma

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

    Valérie Devauchelle-Pensec;Xavier Mariette;Sandrine Jousse-Joulin;Jean-Marie Berthelot

  • Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Benjamin Terrier;Zahir Amoura;Philippe Ravaud;Eric Hachulla

  • Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival

    Marc Humbert;Azzedine Yaici;Pascal de Groote;David Montani

  • Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome

    Raphaèle Seror;Christelle Sordet;Loic Guillevin;Eric Hachulla

Frequent Co-Authors

Luc Mouthon
Luc Mouthon Université Paris Cité
Jean Sibilia
Jean Sibilia University of Strasbourg
Yannick Allanore
Yannick Allanore Université Paris Cité
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Marc Humbert
Marc Humbert University of Paris-Saclay
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Oliver Distler
Oliver Distler University of Zurich
Paolo Airò
Paolo Airò University of Brescia
Zahir Amoura
Zahir Amoura Université Paris Cité
Xavier Puéchal
Xavier Puéchal Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, there are several alternative online degrees and pathways to explore in the healthcare field. For those interested in administrative roles rather than clinical practice, pursuing a healthcare administration degree can offer leadership opportunities in hospitals, clinics, and organizations.

Specialized support roles such as online medical billing and coding schools that accept fafsa can be an accessible entry point into healthcare, especially for those seeking online study with financial aid options.

For aspiring nurses, there are nursing school that don't require teas, making admission less stressful and allowing students to focus immediately on their nursing education. Those already working as registered nurses may look to advance their careers via an rn to np bridge program, transitioning toward becoming a nurse practitioner.

These related online programs offer flexible pathways for those looking to start or advance a healthcare career, often with fewer barriers to entry and diverse opportunities for growth.

Best Scientists Citing Eric Hachulla

Trending Scientists

Recently Published Articles